Regulatory | 2cureX

Regulatory Show all

October 25 | 2023

NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL)

August 24 | 2023

2cureX publishes interim report for Q2 2023

May 25 | 2023

Kommuniké från årsstämma i 2cureX AB

May 25 | 2023

2cureX publishes interim report for the first quarter of 2023

April 27 | 2023

Kallelse till årsstämma i 2cureX AB (publ)

April 27 | 2023

Notice of annual general meeting of 2cureX AB (publ)

April 25 | 2023

2cureX’s CEO Fernando Andreu purchases shares in the company

April 20 | 2023

2cureX offentliggör årsredovisning för räkenskapsåret 2022

April 20 | 2023

2cureX publishes the annual report for the fiscal year 2022

April 12 | 2023

2cureX has received a grant from the Innovation Fund Denmark to support clinical development of a novel IndiTreat® product.

April 6 | 2023

2cureX strengthens its IndiTreat® automation project with a prestigious grant from the German Federal Ministry of Education and Research

February 23 | 2023

2cureX publishes interim report for the fourth quarter and full year of 2022

February 15 | 2023

Invitation to 2cureX webcast on Year-End Report and latest news on February 24, 2023

February 10 | 2023

Announcement from extraordinary general meeting 2cureX AB

February 10 | 2023

Kommuniké från extra bolagsstämma i 2cureX AB

January 23 | 2023

KALLELSE TILL EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL)

January 23 | 2023

NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL)

January 19 | 2023

2cureX announces final results regarding 2022 goals